Search for: "U.S. v. Davis" Results 1 - 20 of 3,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2024, 9:01 pm by Vikram David Amar and Jason Mazzone
Such issues were precisely raised in a 2006 ruling (albeit one that was later vacated as moot, which eliminates any precedential value) from the U.S. [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
21 Apr 2024, 2:35 pm
App’x 364, 366–67 (9th Cir. 2018) (considering personal contacts between the appellant and state of Washington to find personal jurisdiction to enforce a foreign arbitral award); S & Davis Int’l, Inc. v. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]